QuickView for AHSA1;jsessionid=BB00502B7E785F08F8DBB588B0A0C812;jsessionid=8CAE4D2F6D2ADAA7000690C3A4BABDF2;jsessionid=59527D2BB9ADB40D0FF86D690D2CAA77;jsessionid=7F4E500892A79E27C46CA5D54B2ABAC8;jsessionid=DFF780B5C620BEFC9E0FD3E08D27AAF9;jsessionid=733F9215B5A1E536E1541363AB26899A;jsessionid=3F578842644EA878C1C422C93CC993E6;jsessionid=83A863D1E406B09E751B90DC2181DE8B;jsessionid=2A9CEC37557D33F48DF2596252D7D836 (gene)

1. AHSA1 is a promising therapeutic target for cellular proliferation and proteasome inhibitor resistan…
2. Co-chaperones TIMP2 and AHA1 Competitively Regulate Extracellular HSP90:Client MMP2 Activity and Mat…
3. A chemical compound inhibiting the Aha1-Hsp90 chaperone complex.
4. Cooperative Nucleotide Binding in Hsp90 and Its Regulation by Aha1.
5. A Split Renilla Luciferase Complementation Assay for the Evaluation of Hsp90/Aha1 Complex Disruptors…

There were no clinical trials for AHSA1;jsessionid=BB00502B7E785F08F8DBB588B0A0C812;jsessionid=8CAE4D2F6D2ADAA7000690C3A4BABDF2;jsessionid=59527D2BB9ADB40D0FF86D690D2CAA77;jsessionid=7F4E500892A79E27C46CA5D54B2ABAC8;jsessionid=DFF780B5C620BEFC9E0FD3E08D27AAF9;jsessionid=733F9215B5A1E536E1541363AB26899A;jsessionid=3F578842644EA878C1C422C93CC993E6;jsessionid=83A863D1E406B09E751B90DC2181DE8B;jsessionid=2A9CEC37557D33F48DF2596252D7D836